Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Top GSK scientist urges Alzheimer’s push
FT.com
Tuesday, September 6, 2011 - 11:44am
tags:
GSK, Alzheimer's disease
Extraordinary Restructure Of Valeant Pharmaceuticals
GuruFocus
Sunday, September 4, 2011 - 10:35am
tags:
Valeant Pharmaceuticals
Protalix BioTherapeutics: Near-Term Catalysts With Big Upside Potential
Seeking Alpha
Sunday, September 4, 2011 - 10:27am
tags:
Protalix BioTherapeutics, Gaucher disease, taliglucerase alfa
A Hidden Reason Why the Future Looks Bright for Jazz Pharmaceuticals
Motley Fool
Sunday, September 4, 2011 - 10:23am
tags:
Jazz Pharmaceuticals
Death of Medicis CEO’s Girlfriend Was a Suicide, Not a Crime, Sheriff Says
Bloomberg
Saturday, September 3, 2011 - 9:09am
tags:
Jonah Shacknai, Medicis
[video] The Next Big Thing In Biotech: Exelixis
TheStreet.com
Friday, September 2, 2011 - 2:15pm
tags:
Exelixis
FDA Action Date for Salix's Relistor
Yahoo/Zacks.com
Friday, September 2, 2011 - 2:14pm
tags:
FDA, Salix, Relistor, Progenics Pharmaceuticals
Vivus says FDA accepts application on ED drug
Yahoo/AP
Friday, September 2, 2011 - 2:13pm
tags:
FDA, Vivus, erectile dysfunction, Avanafil
Top 10 Biotech Stocks Loved By Hedge Funds
Seeking Alpha
Friday, September 2, 2011 - 2:11pm
tags:
Gilead, Cephalon, Amgen, Life Technologies, Biogen Idec, Illumina, Medicis, NPS Pharmaceuticals, Charles River Laboratories, Dendreon
Survey Says Oncologists Not So Hot On Provenge
Forbes
Friday, September 2, 2011 - 2:10pm
tags:
oncologists, Provenge, Dendreon, prostate cancer
AstraZeneca Falls as Crestor Study Results Not Significant
Bloomberg
Friday, September 2, 2011 - 12:54pm
tags:
Crestor, AstraZeneca, Pfizer, Lipitor, statins
Next Week Could Be Big for Johnson & Johnson: Analyst
Barron's
Friday, September 2, 2011 - 12:13pm
tags:
JNJ, bloodthinners, Xarelto
Sanofi: We'll sell generic Lipitor in France
Yahoo/AP
Friday, September 2, 2011 - 12:11pm
tags:
Lipitor, generics, Sanofi, France, Pfizer, statins
Baxter sues Teva over propofol liability suits
Fierce Pharma
Thursday, September 1, 2011 - 12:38pm
tags:
Baxter, propofol, Teva Pharmaceuticals, lawsuits
Bain, 2 drugmakers still in race for GSK consumer portfolio
Fierce Pharma
Thursday, September 1, 2011 - 12:19pm
tags:
Bain Capital, GSK, OTC
The Big Bet on YM BioSciences
Motley Fool
Thursday, September 1, 2011 - 12:11pm
tags:
YM BioSciences, myelofibrosis, ruxolitinib, CYT387, Novartis, Incyte
4 Leading Medical Stocks With A Healthy Future
Seeking Alpha
Thursday, September 1, 2011 - 12:10pm
tags:
Mako Surgical, Athenahealth, Jazz Pharmaceuticals, Questcor
Selecta lands malaria vaccine deal, names new CSO
Bizjournals.com
Thursday, September 1, 2011 - 12:06pm
tags:
Selecta, malaria
Shire Enters a Crowded Market
Motley Fool
Thursday, September 1, 2011 - 11:37am
tags:
Shire, Firazyr, Dyax, angioedema, CSL
Biotech Busts And Breakthroughs For August
Forbes
Thursday, September 1, 2011 - 11:34am
tags:
Mako Surgical, Luminex, Regeneron, Pharmasset, ViroPharma, Dendreon, Pacific Biosciences, ZOLL Medical, Savient, Human Genome Sciences

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.